ACTRN12618000596202
Terminated
未知
An evidence-based intervention (Fit for Treatment”) to prevent cancer treatment-induced toxicities in cancer patients: An effectiveness-implementation hybrid study
Tina Skinner0 sites41 target enrollmentApril 17, 2018
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Any histologically-confirmed diagnosis of cancer
- Sponsor
- Tina Skinner
- Enrollment
- 41
- Status
- Terminated
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\>18 years of age
- •\- Cancer patients prescribed any anti\-cancer treatment
- •\- \>1 month post\-surgery
- •\- No co\-morbid condition or falls risk that could prevent safe completion of the intervention
- •\- Cognitively capable of consent
Exclusion Criteria
- •\- Cancer patients prescribed any anti\-cancer treatment
- •\- Not planning to undergo surgery during the intervention period
- •\- Any intellectual or physical disability which would make exercise intervention participation unsafe for the individual
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Effects and Implementation of the ACT Program in CearáRBR-5gbhw5wFaculdade de Medicina de Ribeirão Preto da Universidade de São Paulo
Completed
Not Applicable
Implementation of an intervention for the assessment, diagnosis, and management of urinary incontinence and lower urinary tract symptoms on wards that admit adult patients.ACTRN12621000883819Hunter New England Local Health District2,792
Not yet recruiting
Phase 1
Randomized controlled clinical trial on the intervention of activating blood circulation and removing toxicity Chinese herbal compound in patients with borderline coronary lesionsITMCTR2200005923Xiyuan Hospital of China Academy of Chinese Medical Sciences
Not yet recruiting
Phase 2
Drakshathi chooram for Pandu noi anaemia A pilot studyHealth Condition 1: D539- Nutritional anemia, unspecifiedCTRI/2022/02/040567ational institute ofsiddha
Not yet recruiting
Phase 3
therapeutic effectiveness of Siddha formulation Thanneervittan Nei in the management of Moothirakiricharam (Urinary Tract Infection) â?? A Pilot studyHealth Condition 1: N390- Urinary tract infection, site notspecifiedCTRI/2022/03/040777ational institute of siddha